Skip to main content
Signal8

ARMISTICE CAPITAL, LLC

ARMISTICE CAPITAL, LLC is an Investment Adviser institutional filer with the SEC under CIK 1601086, reporting 323 portfolio positions, with 20 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

  • State of incorporation: DE
  • Filing type: 13F-HR
  • Latest reporting period: 2026-06-30
  • Last filed: 2026-08-14

Top 10 portfolio positions

The largest reported holdings in ARMISTICE CAPITAL, LLC's most recent 13F filing, ranked by reported market value.

  1. MADRIGAL PHARMACEUTICALS INC (MDGL)
  2. SUPERNUS PHARMACEUTICALS (SUPN)
  3. CYTOKINETICS INC (CYTK)
  4. INCYTE CORP (INCY)
  5. NEUROCRINE BIOSCIENCES INC (NBIX)
  6. TRAVERE THERAPEUTICS INC (TVTX)
  7. AGIOS PHARMACEUTICALS INC (AGIO)
  8. PTC THERAPEUTICS INC (PTCT)
  9. UNITEDHEALTH GROUP INC (UNH)
  10. FRESHPET INC (FRPT)
/